US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 2, 2013 (13 years ago)

Desmopressin Acetate

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Label Mixup: DESMOPRESSIN ACETATE, Tablet 0.1 mg may have potentially been mislabeled as the following drug: LOXAPINE, Capsule, 5 mg, NDC 00591036901, Pedigree: AD46426_7, EXP: 5/15/2014.

What was recalled

DESMOPRESSIN ACETATE, Tablet 0.1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591246401.

Recalling firm
Aidapak Services, LLC
Origin
WA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-968-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Desmopressin recalls

See all
Class II · Moderate risk Ongoing

Desmopressin Nasal Spray

Reason Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.

Apotex Corp. NDC 60505-0815-0 D-0510-2026
Class II · Moderate risk Terminated

Desmopressin Acetate Tablet

Reason Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.

RemedyRepack Inc. D-0077-2023
Class II · Moderate risk Terminated

Desmopressin Acetate Tablets

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 16714-884-01 D-1171-2022
Class II · Moderate risk Terminated

Desmopressin Acetate Injection USP

Reason Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Teva Pharmaceuticals USA NDC 0703-5051-01 D-0272-2021